摘要
目的:分析骨肉瘤肺转移患者的年龄、性别和肺转移灶数目等因素对患者生存的影响。方法:采用多因素回归分析法分析71例骨肉瘤肺转移患者生存相关因素。结果:71例骨肉瘤肺转移患者的2年生存率为38.0%(27/71),中位生存时间20个月;年龄<12岁与≥20岁患者的生存差异有统计学意义(P=0.005);单纯化疗与化疗联合γ刀放射治疗或化疗联合局部手术治疗的生存差异均有统计学意义(P=0.030,P=0.001)。1~2个肺转移灶与>2个肺转移灶的生存差异有统计学意义(P<0.01);初治与复治患者的生存差异无统计学意义(P=0.55)。多因素回归分析显示多学科综合治疗和肺转移灶数目是影响预后的独立因素(P=0.004,P=0.003)。结论:不同转移灶数目对骨肉瘤肺转移的生存时间有影响;多学科综合治疗可改善患者预后。
Objective: To analyze the influence of age, gender, and number of metastases on the survival of osteosarcoma patients with lung metastases. Methods:Survival related factors for 71 osteosarcoma patients with lung metastases were analyzed using the multivariate COX regression analysis. Results:The 2-year survival rate was 38.0% (27/71) and the median survival time was 20 months for the 71 osteosarcoma patients with lung metastases. There were significant differences between patients aging 〈12 years and ≥20 years old (P=0.005). The survival differences were significant between single chemotherapy group and the chemotherapy plus gamma radiation therapy group or chemotherapy combined with local surgery group (P=0.030, P=0.001). The survival difference was significant between patients with 1-2 metastases lesions and those with more than 2 metastases lesions (P〈0.01). There was no significant difference in the survival rate between initially-treated patients with osteosarcoma and secondary treated patients with osteosarcoma (P=0.55). Multivariate regression analysis showed that multi-modality treatment and the number of metastasis lesions were independent prognostic factors (P=0.004, P=0.003). Conclusion: The number of metastatic lesions affected the survival time of osteosarcoma patients with lung metastases. Multi-modality treatment could improve the prognosis of patients.
出处
《肿瘤》
CAS
CSCD
北大核心
2009年第5期471-474,共4页
Tumor
基金
上海市科学技术委员会科研计划项目资助项目(编号:064119637)
关键词
骨肉瘤
肿瘤转移
存活率
预后
随访研究
Osteosarcoma, Neoplasm metastasis
Survival rate
Prognosis
Follow-up studies